119 related articles for article (PubMed ID: 33380522)
1. TrkC Is Essential for Nephron Function and Trans-Activates Igf1R Signaling.
Lepa C; Hoppe S; Stöber A; Skryabin BV; Sievers LK; Heitplatz B; Ciarimboli G; Neugebauer U; Lindenmeyer MT; Cohen CD; Drexler HCA; Boor P; Weide T; Pavenstädt H; George B
J Am Soc Nephrol; 2021 Feb; 32(2):357-374. PubMed ID: 33380522
[TBL] [Abstract][Full Text] [Related]
2. Tropomyosin-related kinase C (TrkC) enhances podocyte migration by ERK-mediated WAVE2 activation.
Gromnitza S; Lepa C; Weide T; Schwab A; Pavenstädt H; George B
FASEB J; 2018 Mar; 32(3):1665-1676. PubMed ID: 29162704
[TBL] [Abstract][Full Text] [Related]
3. Altering a histone H3K4 methylation pathway in glomerular podocytes promotes a chronic disease phenotype.
Lefevre GM; Patel SR; Kim D; Tessarollo L; Dressler GR
PLoS Genet; 2010 Oct; 6(10):e1001142. PubMed ID: 21060806
[TBL] [Abstract][Full Text] [Related]
4. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.
Meliambro K; Wong JS; Ray J; Calizo RC; Towne S; Cole B; El Salem F; Gordon RE; Kaufman L; He JC; Azeloglu EU; Campbell KN
J Biol Chem; 2017 Dec; 292(51):21137-21148. PubMed ID: 28982981
[TBL] [Abstract][Full Text] [Related]
5. Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis.
Lenoir O; Milon M; Virsolvy A; Hénique C; Schmitt A; Massé JM; Kotelevtsev Y; Yanagisawa M; Webb DJ; Richard S; Tharaux PL
J Am Soc Nephrol; 2014 May; 25(5):1050-62. PubMed ID: 24722437
[TBL] [Abstract][Full Text] [Related]
6. Activation of Galpha q-coupled signaling pathways in glomerular podocytes promotes renal injury.
Wang L; Fields TA; Pazmino K; Dai Q; Burchette JL; Howell DN; Coffman TM; Spurney RF
J Am Soc Nephrol; 2005 Dec; 16(12):3611-22. PubMed ID: 16267159
[TBL] [Abstract][Full Text] [Related]
7. Neurotrophin-3 Regulates Synapse Development by Modulating TrkC-PTPσ Synaptic Adhesion and Intracellular Signaling Pathways.
Han KA; Woo D; Kim S; Choii G; Jeon S; Won SY; Kim HM; Heo WD; Um JW; Ko J
J Neurosci; 2016 Apr; 36(17):4816-31. PubMed ID: 27122038
[TBL] [Abstract][Full Text] [Related]
8. The redox sensitive glycogen synthase kinase 3β suppresses the self-protective antioxidant response in podocytes upon oxidative glomerular injury.
Li C; Ge Y; Peng A; Gong R
Oncotarget; 2015 Nov; 6(37):39493-506. PubMed ID: 26567873
[TBL] [Abstract][Full Text] [Related]
9. Twisted gastrulation, a BMP antagonist, exacerbates podocyte injury.
Yamada S; Nakamura J; Asada M; Takase M; Matsusaka T; Iguchi T; Yamada R; Tanaka M; Higashi AY; Okuda T; Asada N; Fukatsu A; Kawachi H; Graf D; Muso E; Kita T; Kimura T; Pastan I; Economides AN; Yanagita M
PLoS One; 2014; 9(2):e89135. PubMed ID: 24586548
[TBL] [Abstract][Full Text] [Related]
10. A peptidomimetic of NT-3 acts as a TrkC antagonist.
Brahimi F; Malakhov A; Lee HB; Pattarawarapan M; Ivanisevic L; Burgess K; Saragovi HU
Peptides; 2009 Oct; 30(10):1833-9. PubMed ID: 19647025
[TBL] [Abstract][Full Text] [Related]
11. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type-2-receptor stimulation ameliorates focal and segmental glomerulosclerosis in mice.
Liao MC; Miyata KN; Chang SY; Zhao XP; Lo CS; El-Mortada MA; Peng J; Chenier I; Yamashita M; Ingelfinger JR; Chan JSD; Zhang SL
Clin Sci (Lond); 2022 May; 136(10):715-731. PubMed ID: 35502764
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory smads and tgf-Beta signaling in glomerular cells.
Schiffer M; Schiffer LE; Gupta A; Shaw AS; Roberts IS; Mundel P; Böttinger EP
J Am Soc Nephrol; 2002 Nov; 13(11):2657-66. PubMed ID: 12397035
[TBL] [Abstract][Full Text] [Related]
14. Genetic ablation of SLK exacerbates glomerular injury in adriamycin nephrosis in mice.
Woychyshyn B; Papillon J; Guillemette J; Navarro-Betancourt JR; Cybulsky AV
Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1377-F1390. PubMed ID: 32308020
[TBL] [Abstract][Full Text] [Related]
15. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease.
Veron D; Reidy KJ; Bertuccio C; Teichman J; Villegas G; Jimenez J; Shen W; Kopp JB; Thomas DB; Tufro A
Kidney Int; 2010 Jun; 77(11):989-99. PubMed ID: 20375978
[TBL] [Abstract][Full Text] [Related]
17. Podocyte-specific knockout of cyclooxygenase 2 exacerbates diabetic kidney disease.
Wang L; Sha Y; Bai J; Eisner W; Sparks MA; Buckley AF; Spurney RF
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F430-F439. PubMed ID: 28490532
[TBL] [Abstract][Full Text] [Related]
18. A role for NPY-NPY2R signaling in albuminuric kidney disease.
Lay AC; Barrington AF; Hurcombe JA; Ramnath RD; Graham M; Lewis PA; Wilson MC; Heesom KJ; Butler MJ; Perrett RM; Neal CR; Herbert E; Mountjoy E; Atan D; Nair V; Ju W; Nelson RG; Kretzler M; Satchell SC; McArdle CA; Welsh GI; Coward RJM
Proc Natl Acad Sci U S A; 2020 Jul; 117(27):15862-15873. PubMed ID: 32561647
[TBL] [Abstract][Full Text] [Related]
19. Rhophilin-1 is a key regulator of the podocyte cytoskeleton and is essential for glomerular filtration.
Lal MA; Andersson AC; Katayama K; Xiao Z; Nukui M; Hultenby K; Wernerson A; Tryggvason K
J Am Soc Nephrol; 2015 Mar; 26(3):647-62. PubMed ID: 25071083
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria.
Dai C; Saleem MA; Holzman LB; Mathieson P; Liu Y
Kidney Int; 2010 Jun; 77(11):962-73. PubMed ID: 20375988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
